ASCL1 and small cell lung carcinoma: Previously published proteomic data on human SCLC cell lines revealed that the ASCL1-driven SCLC-A molecular subtype features a distinct metabolic phenotype, indicating a shift toward increased oxidative phosphorylation (OXPHOS) [18].